Project Grant R01AI187335
Award Date
11/15/24
Completion Date
10/31/29
Dollars Obligated
$652K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This $658,273 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research to investigate how Herpes Simplex Virus 1 (HSV-1) interacts with and regulates the NLRP1 inflammasome pathway in human skin cells. The key objectives are to 1) determine how the HSV-1 ICP0 protein activates stress-activated protein kinases and the consequences for NLRP1 inflammasome activation, 2)...
This federal Project Grant award for $384,363, issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the role of the protein Pellino1 in regulating antiviral immunity in the skin. The research aims to define how Pellino1 functions to limit the spread and severity of herpes simplex virus infection in the skin epidermis and hair follicles. The project utilizes both mouse...
This $881,878 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the crosstalk between keratinocytes (skin cells) and tissue-resident memory T-cells, and how this interaction influences the recurrence of herpes simplex virus (HSV) infections in genital skin. The research team at the Fred Hutchinson Cancer Center, along with sub-awardees from the...
The University of Kansas Center for Research Inc. was awarded a $381,486 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, titled "Role of ICP0 Dimerization in Herpes Simplex Virus Pathogenesis," aims to identify the mechanisms by which the herpes simplex virus (HSV) protein ICP0 binds to itself to enhance viral transcription and replication. The research will focus...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $1,486,800.00 to the Albert Einstein College of Medicine to conduct research on the role of TNFRSF14 signaling in promoting antibody-dependent cell-mediated cytotoxicity (ADCC) for the development of a herpes simplex virus (HSV) vaccine. The research will leverage a novel single-cycle HSV vaccine strain and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $236,292 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Tufts University School of Medicine to apply new methods to isolate and characterize the structures of key herpes simplex virus (HSV) glycoprotein complexes involved in viral entry. The 2-year project aims to use antibodies to stabilize the GD/GH/GL glycoprotein complex and non-detergent extraction methods to isolate the GH/GL/GB...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding research to investigate host protein degradation mechanisms used by Herpes Simplex Virus Type 1 (HSV-1) in neuronal cells. The primary objectives are to: 1) identify host proteins degraded in neurons following HSV-1 infection, and 2) determine the roles of the viral proteins ICP0 and the PUL55/PUL13/PUS10...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $298,350 to Washington State University to conduct research on the intracellular pathway utilized by the Herpes Simplex Virus (HSV) during entry into human epithelial cells. The key objectives are to demonstrate that incoming HSV utilizes a retrograde transport pathway to the Golgi apparatus prior to reaching...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $729,006 to The Children's Hospital of Philadelphia Research Institute to conduct research on how adenovirus manipulates host cellular RNA binding proteins. The research aims to define the mechanisms by which adenovirus modulates RNA binding protein methylation to promote viral infection through changes to...
This $734,184 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research on the mechanisms of parainfluenza virus genome replication. The 5-year project, commencing on March 1, 2025, aims to provide novel insights into the regulation of transcription and replication processes for non-segmented negative-strand RNA viruses, which include important human pathogens...